ABBvie Chairman and CEO Richard A.Gonzalez suggest
Post# of 148282
(Total Views: 798)
Posted On: 10/24/2021 3:46:20 PM
ABBvie Chairman and CEO Richard A.Gonzalez suggested 10 years and between $2 and 3 Billion USD invested to bring a drug to market...and less than 12% will ever see the light of day...Humira... their worldwide top-selling drug expires in its exclusivity in 2023...
Dr. Lishomwa (Lish) Ndhlovu who in June of this year was still a scientific advisor to ABBvie...will join among others on the BOD for Cytodyn...just trying to connect a few dots.
Dr. Ndhlovu and Dr. Jonah Sacha have worked in concert on HIV...and as JLang,... I believe has pointed out on several occasions the latter...is the only Dr. that has "cured" a patient of HIV.
I look forward to our new slate...minus the fangs.
Dr. Lishomwa (Lish) Ndhlovu who in June of this year was still a scientific advisor to ABBvie...will join among others on the BOD for Cytodyn...just trying to connect a few dots.
Dr. Ndhlovu and Dr. Jonah Sacha have worked in concert on HIV...and as JLang,... I believe has pointed out on several occasions the latter...is the only Dr. that has "cured" a patient of HIV.
I look forward to our new slate...minus the fangs.
(10)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼